Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Church & Dwight (CHD) Q1 Earnings & Revenues Beat Estimates

Published 05/04/2017, 03:30 AM
Updated 07/09/2023, 06:31 AM
STZ
-
CAG
-
CHD
-
LW
-

Church & Dwight Company, Inc. (NYSE:CHD) posted better-than-expected results in the first quarter of 2017, wherein both earnings and revenues beat the Zacks Consensus Estimate.

Adjusted earnings (excluding charges related to the sale of the Brazilian Specialty Products business completed in March and including the positive impact from adopting the new stock option accounting standard) of 52 cents per share beat the Zacks Consensus Estimate of 46 cents by 13%. In fact, earnings outpaced the Zacks Consensus Estimates in 10 out of the past 13 quarters, including the current one.

Adjusted earnings increased 20.9% from the year-ago results and also exceeded the management’s range of 1–2% growth, boosted by higher sales and improved margins.

Notably, Church & Dwight’ shares have also been rising on a year-to-date basis. The stock has increased 14.5% on a year-to-date basis in comparison to the Zacks categorized Consumer Staple sector, which gained 6.5%. The sector is part of the bottom 38% of the Zacks Classified sectors (10 out of the 16).

Quarter in Detail

The company reported sales of $877.2 million in the first quarter. Sales marginally beat the Zacks Consensus Estimate of $870 million by 0.8% and was up 3.3% from the prior-year quarter. In fact, sales outpaced the Zacks Consensus Estimates in 12 out of the past 14 quarters, including the current one.

Organic sales increased 2.3% from the prior-year quarter, exceeding the company’s range of 1 –2% as higher volumes of 2.7% were offset by adverse impact of pricing and product mix, which reduced sales by 0.4%. While organic sales increased 2.6% in Global Consumer Products business (Consumer Domestic and Consumer International), it declined 0.3% in Specialty Products business. Organic growth in the first quarter was weaker than last year’s growth of 5.2%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Adjusted gross margin expanded 110 basis points in the first quarter, driven by productivity initiatives and the impact of a higher margin acquired business, offset by higher input costs. Operating margin increased 170 basis points in the quarter.

Church & Dwight Company, Inc. Price, Consensus and EPS Surprise

Church & Dwight Company, Inc. Price, Consensus and EPS Surprise | Church & Dwight Company, Inc. Quote

Segment Details

Consumer Domestic: Segment net sales increased 1.8% to $659.7 million, while organic sales inched up 0.8% primarily driven by 1.1% higher volume growth, partially offset by a dip of 0.3% attributable to product mix and pricing.

ARM & HAMMER liquid and unit dose laundry detergents, BATISTE dry shampoo, ARM & HAMMER baking soda, ARM & HAMMER cat litter led to the increase but were negatively impacted by declines in TROJAN condoms and XTRA laundry detergent.

Consumer International: Segment net sales grew 12.3% to $143.1 million. Organic sales increased 11.8% on 13.2% higher volume of partially offset by unfavorable product mix and pricing, which led to a 1.4% decline. BATISTE, FEMFRESH and OXICLEAN in the export business and ARM & HAMMER liquid laundry detergent and ARM & HAMMER cat litter in Canada contributed to the increase.

Specialty Products: The segment sales showed a slight increase of 0.8% to $74.4 million. Organic sales however dipped 0.3% due to lower volumes in the specialty chemical sector of the business. Encouragingly, the animal productivity business improved in both price and volume on higher demand from the U.S. dairy industry as milk prices and dairy farm profitability appear to have stabilized.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Acquisition of Agro BioSciences

The company acquired Agro BioSciences, Inc. for $75 million on May 1. Agro BioSciences is an innovator and leader in developing custom probiotic products for poultry, cattle and swine. This business complements the company’s animal productivity business. The acquisition is expected to be neutral to EPS in 2017 due to transition costs. In 2018, the company expects the acquisition to be accretive to EPS.

Sale of Brazilian Chemical Business

In March, the company completed the sale of its chemical business in Brazil for $4.5 million in order to focus on its Brazilian consumer business.

Other Financial Update

Church & Dwight ended the quarter with cash and cash equivalents of $139.5 million, long-term debt of $692.9 million, and total shareholders’ equity of $1,936 million.

In the first quarter, the company generated cash flow from operations of $131.5 million and incurred capital expenditure of $2.8 million. Additionally, the company’s total free cash flow for the quarter totaled $128.7 million. For 2017, management expects adjusted free cash flow to exceed adjusted net income. The company expects to generate over $1.8 billion in free cash flow over the next three years.

Guidance for 2017

Church & Dwight remains optimistic about its future performance on the back of a stable portfolio of value and premium products, launch of new and innovative products, aggressive productivity programs and tight management of overhead expenses, along with robust sales and earnings growth. However, it also expects a competitive environment in 2017 due to new product introductions by competitors and persistent pricing pressure. The company expects rising commodity costs and foreign currency headwinds to prevail in 2017.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company expects reported and organic sales growth of approximately 3% for 2017 driven by innovations. Further, it anticipates gross margin expansion of 40 bps year over year (expected 60 bps year over year earlier), despite rising commodity costs and currency headwinds. Also, operating margin is estimated to improve nearly 40 bps, on adjustment for pension settlement cost and Brazil charges.

Considering all these factors, management now envisions adjusted earnings per share in 2017 to grow by 8.5%, compared with 7% expected earlier. Excluding negative currency impact of 1%, the company forecasts adjusted earnings to grow 9.5% for 2017.

Second Quarter Outlook

For the second quarter, the company expects reported and organic sales growth of approximately 1 to 2%. While gross margin for the first half is expected to be flat, adjusted earnings are expected to increase approximately 5%.

Zacks Rank & Key Picks

Church & Dwight currently carries a Zacks Rank #3 (Hold).

Better-ranked stocks in the consumer staple sector include Constellation Brands, Inc. (NYSE:STZ) , ConAgra Foods Inc. (NYSE:CAG) and Lamb Weston Holdings Inc. (NYSE:LW) . While Constellation Brands sports a Zacks Rank #1 (Strong Buy) and has a long-term earnings growth of 17.8%, ConAgra and Lamb Weston carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

While ConAgra Foods has a long-term earnings growth rate of 8%, Lamb Weston has a long-term earnings growth rate of 4.2%.

Will You Make a Fortune on the Shift to Electric Cars?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>



Constellation Brands Inc (STZ): Free Stock Analysis Report

ConAgra Foods Inc. (CAG): Free Stock Analysis Report

Lamb Weston Holdings Inc. (LW): Free Stock Analysis Report

Church & Dwight Company, Inc. (CHD): Get Free Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.